MIGMA
MIGMA is an Argentine-origin biotech startup that uses AI to design and validate synergistic antioxidant mixtures for B2B customers in food and beverages, pet food, cosmetics, and lubricants. It operates a three-step Design-Predict-Validate service model grounded in peer-reviewed transformer-based chemistry models.
- Company typePrivate
- Founded2024
- HeadquartersDover, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What MIGMA does
MIGMA is an Argentine-origin, Delaware-incorporated biotech startup that applies artificial intelligence to the discovery and design of synergistic antioxidant mixtures. The company's core offering is a three-step service model — Design, Predict, Validate — in which it designs custom antioxidant formulations, uses proprietary AI models (including transformer-based architectures and data mining on chemical informatics via RDKit) to predict efficacy, and then validates predictions in laboratory settings. The technology is grounded in peer-reviewed research published in the ACS Journal of Agricultural and Food Chemistry and Nature Scientific Reports, including the first published AI demonstration of Natural Deep Eutectic Solvent (NADES) formation prediction and a proprietary eutXG melting-point prediction model. Reported performance claims include antioxidant solutions delivering up to 70% longer expiration dates for treated products.
MIGMA targets four B2B verticals: food & beverages (primary), pet food, cosmetics, and lubricants & oils, addressing oxidation-driven degradation such as loss of freshness, flavor, texture, and nutritional value. The go-to-market is consultative enterprise sales, with revenue mechanics spanning professional services (predictive model generation, data modeling, R&D and consulting) and longer-term licensing and patenting of novel formulations. Pricing is not publicly disclosed and operates on a quote-based, tailored-engagement basis.
The company is led by three founders — Sofía Garcia Franco (CEO), Lucas Ayres (CTO), and Carlos Garcia (CSO) — operating with a 1–10 employee headcount. Capital partners include Atento Capital, Eatable Adventures, Gridx, Next Sequence, INCUBATE, Draper House, and Catal15t, with cumulative disclosed funding of approximately $541,000 across a pre-seed and a subsequent 2026 round. In 2025 the company received the Most Sustainable FoodTech Startup award at the ftalks Food Summit in Spain and the Best Startup Award at Expo AgroFuturo AGSTAR in Colombia, providing European and broader LATAM market visibility.
MIGMA firmographics
Firmographics- Name
- MIGMA
- Legal name
- Migma Inc.
- Website
- https://migma.co
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MIGMA is an Argentine-origin biotech startup that uses AI to design and validate synergistic antioxidant mixtures for B2B customers in food and beverages, pet food, cosmetics, and lubricants. It operates a three-step Design-Predict-Validate service model grounded in peer-reviewed transformer-based chemistry models.
- Ownership category
- akta.pro rank
MIGMA industry classification
Industry- Product category
- AI-driven Antioxidant Formulation Services
- NAICS
- Food Manufacturing (311), Mayonnaise, Dressing, and Other Prepared Sauce Manufacturing (311941)
- SIC
- Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro primary industry
- Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends) (CRADAOAO)
- akta.pro secondary industries
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Predictive Microbiology & Shelf-Life Risk Modeling (AFALAOAL)
Keywords
Where MIGMA is headquartered
LocationHeadquarters
- HQ city
- Dover
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MIGMA business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Predictive Model Generation Services: Creating advanced models to predict future trends and optimize outcomes based on data analysis for clients in target industries.
- Data Modeling Services: Structuring and analyzing data to create valuable insights for business and research applications.
- R&D and Consulting Services: Research and development expertise along with tailored consulting services to drive innovation for client products.
- New Formulations Discovery: Innovating and discovering new formulas to improve client products and processes, likely on a project or licensing basis.
- Licensing and Patenting: Securing intellectual property through patents and licensing to protect innovations and generate ongoing royalty revenue.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
MIGMA product offering
Product offeringCore offering
MIGMA applies artificial intelligence to design, predict, and validate custom synergistic antioxidant mixtures for product manufacturers. Through a three-step Design-Predict-Validate process, the company delivers tailored antioxidant formulations for the food & beverage, pet food, cosmetics, and lubricants industries, achieving up to 70% longer product expiration dates. The company also offers predictive model generation, data modeling, R&D consulting, new formulations discovery, and licensing/patenting services.
Product overview
MIGMA offers a three-step integrated solution for antioxidant optimization: Design (custom antioxidant mixture design tailored to product requirements), Predict (AI-powered efficacy prediction using proprietary algorithms), and Validate (real-world testing with state-of-the-art equipment). The company also provides complementary services including predictive model generation, data modeling, R&D and consulting, new formulations discovery, and licensing/patenting. Their solution achieves measurable outcomes such as 70% longer expiration dates for treated products, serving industries including food & beverages, pet food, cosmetics, and lubricants & oils.
Differentiator
Problem solved
Functional benefit
Products and services
- Custom Antioxidant Mixture Design
- Predictive Model Generation
- Data Modeling
- R&D and Consulting Services
- New Formulations Discovery
- Licensing and Patenting
Quantifiable outcome
- Products treated with MIGMA's antioxidant solutions achieve 70% longer expiration dates
- +2 more outcomes
Companies that use MIGMA
Customer profileSegments4 records
Ideal customer profiles3 records
MIGMA technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
MIGMA partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights4 records
MIGMA competitors and assessment
Company assessmentBroad incumbents
- Kemin Industries: Kemin is a global ingredient manufacturer with a large antioxidants and shelf-life solutions portfolio serving food, pet food, and cosmetics — directly competing with MIGMA's value proposition but at vastly larger scale and with established enterprise relationships.
- BASF Nutrition & Health: BASF's Nutrition & Health division supplies antioxidants and food ingredients globally, representing a deep-pocketed incumbent that competes with MIGMA on formulation performance, regulatory support, and supply reliability.
- IFF (DuPont/Danisco): IFF (including the legacy DuPont Nutrition & Biosciences / Danisco portfolio) is a major supplier of food ingredients and antioxidants to CPG manufacturers worldwide, representing the kind of entrenched incumbent MIGMA must displace in procurement decisions.
- ADM: ADM is a global food ingredient and nutrition major with antioxidant and preservation offerings across human food, pet food, and industrial markets — overlapping MIGMA's four target verticals from an incumbent position.
- Ginkgo Bioworks: Ginkgo's synthetic biology platform uses AI to design and produce novel ingredients, making it a broad incumbent with adjacent technology stack and similar B2B ingredient-discovery value proposition, though at much greater scale.
Direct peers
- NotCo: NotCo applies AI (Giuseppe) to plant-based food formulation and ingredient substitution, making it the closest direct peer to MIGMA's AI-driven CPG formulation approach. Both target B2B CPG manufacturers with algorithm-designed ingredient systems.
- Brightseed: Brightseed uses AI to map bioactive compounds in plants for food and health applications, sharing MIGMA's thesis that machine learning can accelerate discovery of functional ingredients with measurable health or preservation benefits.
- Shiru: Shiru operates an AI-powered ingredient discovery platform for food and personal care, directly comparable to MIGMA's Design-Predict-Validate service model and target verticals of food and cosmetics.
Emerging players
- Sensesbit: Co-winner with MIGMA of the ftalks Startups Awards 2025, Sensesbit applies AI to sensory analysis in food — emerging as a sibling food-tech AI startup from the same award cohort, with overlapping customer base (food manufacturers).
Others
- Eatable Adventures: Eatable Adventures is a food-tech accelerator and investor that has funded MIGMA, sitting in MIGMA's ecosystem as both capital provider and gateway to European CPG pilots — relevant as a strategic partner rather than competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
MIGMA social profiles
Digital presenceMIGMA financial estimates
Financial estimateRevenue estimate
Valuation estimate
MIGMA leadership team
Management profileNumber of profiles
Profiles3 records
MIGMA funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MIGMA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MIGMA
What does MIGMA do?
MIGMA applies artificial intelligence to design, predict, and validate custom synergistic antioxidant mixtures for product manufacturers. Through a three-step Design-Predict-Validate process, the company delivers tailored antioxidant formulations for the food & beverage, pet food, cosmetics, and lubricants industries, achieving up to 70% longer product expiration dates. The company also offers predictive model generation, data modeling, R&D consulting, new formulations discovery, and licensing/patenting services.
Is MIGMA a public or private company?
MIGMA is a private company. It is classified as venture growth investor backed and is currently operating.
When was MIGMA founded?
MIGMA was founded in 2024. It employs 1 to 10 people.
Where is MIGMA based?
MIGMA is headquartered in Dover, United States, in the North America region.
How does MIGMA make money?
Five revenue lines are on record. Predictive Model Generation Services are the primary driver. The others are data Modeling Services, R&D and Consulting Services, new Formulations Discovery and licensing and Patenting.
Who are MIGMA's main competitors?
Broad incumbents on record are Kemin Industries, BASF Nutrition & Health, IFF (DuPont/Danisco), ADM and Ginkgo Bioworks. Direct peers are NotCo, Brightseed and Shiru. Sensesbit is listed as an emerging player. Eatable Adventures is listed as an others.
Does MIGMA have an API?
No public API is recorded for MIGMA.
What industry is MIGMA in?
MIGMA's product category is AI-driven Antioxidant Formulation Services. Its primary akta.pro industry code is CRADAOAO, Ingredient Blends & Systems / Custom Formulation (Seasoning Systems, Functional Blends), with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 311 and its SIC code is 2090.